Abstract
A specific radioimmunoassay has been developed capable of detecting 1.5 pmol VIP/l plasma with 95% confidence. The antisera employed reacted most avidly with whole VIP, partly with C terminal, but not with N terminal fragments. In 110 healthy fasting volunteers plasma VIP concentrations were estimated to lie between 0.5 and 21 pmol/l (median 1.7). No significant change was seen after ingestion of a standard test meal.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alford F. P., Bloodm S. R., Nabarro J. D. Glucagon levels in normal and diabetic subjects: use of a specific immunoabsorbent for glucagon radioimmunoassay. Diabetologia. 1977 Jan;13(1):1–6. doi: 10.1007/BF00996319. [DOI] [PubMed] [Google Scholar]
- Barbezat G. O., Grossman M. I. Intestinal secretion: stimulation by peptides. Science. 1971 Oct 22;174(4007):422–424. doi: 10.1126/science.174.4007.422. [DOI] [PubMed] [Google Scholar]
- Bloom S. R., Bryant M. G. Proceedings: The distribution of vasoactive intestinal peptide (VIP) in the primate gastrointestinal tract and characterization of VIP from human tumours. Gut. 1973 Oct;14(10):823–823. [PubMed] [Google Scholar]
- Bloom S. R., Polak J. M., Pearse A. G. Vasoactive intestinal peptide and watery-diarrhoea syndrome. Lancet. 1973 Jul 7;2(7819):14–16. doi: 10.1016/s0140-6736(73)91947-8. [DOI] [PubMed] [Google Scholar]
- Bodanszky M., Klausner Y. S., Said S. I. Biological activities of synthetic peptides corresponding to fragments of and to the entire sequence of the vasoactive intestinal peptide. Proc Natl Acad Sci U S A. 1973 Feb;70(2):382–384. doi: 10.1073/pnas.70.2.382. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bryant M. G., Polak M. M., Modlin I., Bloom S. R., Albuquerque R. H., Pearse A. G. Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance. Lancet. 1976 May 8;1(7967):991–993. doi: 10.1016/s0140-6736(76)91863-8. [DOI] [PubMed] [Google Scholar]
- Ebeid A. M., Murray P., Hirsch H., Wesdorp R. I., Fischer J. E. Radioimmunoassay of vasoactive intestinal peptide. J Surg Res. 1976 Apr;20(4):355–360. doi: 10.1016/0022-4804(76)90025-1. [DOI] [PubMed] [Google Scholar]
- Kerins C., Said S. I. Hyperglycemic and glycogenolytic effects of vasoactive intestinal polypeptide. Proc Soc Exp Biol Med. 1973 Mar;142(3):1014–1017. doi: 10.3181/00379727-142-37165. [DOI] [PubMed] [Google Scholar]
- Nilsson A. Structure of the vasoactive intestinal octacosapeptide from chicken intestine. The amino acid sequence. FEBS Lett. 1975 Dec 15;60(2):322–326. doi: 10.1016/0014-5793(75)80740-x. [DOI] [PubMed] [Google Scholar]
- Russel R. C., Bloom S. R., Fielding L. P., Bryant M. G. Current problems in the measurement of gastrin release. A reproducible measure of physiological gastrin release. Postgrad Med J. 1976 Oct;52(612):645–650. doi: 10.1136/pgmj.52.612.645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Said S. I., Faloona G. R. Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors. N Engl J Med. 1975 Jul 24;293(4):155–160. doi: 10.1056/NEJM197507242930401. [DOI] [PubMed] [Google Scholar]
- Said S. I., Mutt V. Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur J Biochem. 1972 Jul 13;28(2):199–204. doi: 10.1111/j.1432-1033.1972.tb01903.x. [DOI] [PubMed] [Google Scholar]
- Said S. I., Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science. 1970 Sep 18;169(3951):1217–1218. doi: 10.1126/science.169.3951.1217. [DOI] [PubMed] [Google Scholar]
- Schwartz C. J., Kimberg D. V., Sheerin H. E., Field M., Said S. I. Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa. J Clin Invest. 1974 Sep;54(3):536–544. doi: 10.1172/JCI107790. [DOI] [PMC free article] [PubMed] [Google Scholar]